Gilead Sciences Inc (GILD)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
111.79 +0.63 (+0.57%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 111.79 unch (unch) 18:40 ET
for Fri, Mar 28th, 2025
Results
download Want to compare other data? Select FieldsSymbol | GILD | AZN | AMGN | VRTX | BMY |
Company | Gilead Sciences Inc | Astrazeneca Plc ADR | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
Open | 111.15 | 73.70 | 307.44 | 504.79 | 59.40 |
High | 112.38 | 74.19 | 308.17 | 504.79 | 60.11 |
Low | 109.64 | 73.43 | 304.71 | 491.37 | 58.23 |
Last | 111.79 | 73.79 | 306.95 | 492.69 | 60.02 |
Change | +0.63 | +0.95 | +1.18 | -9.86 | +1.12 |
% Change | +0.57% | +1.30% | +0.39% | -1.96% | +1.90% |
Volume | 7,845,100 | 3,427,600 | 1,768,500 | 1,281,000 | 10,791,600 |
20-Day Average Volume | 10,720,840 | 5,295,415 | 3,044,535 | 1,339,665 | 12,667,811 |
Previous Close | 111.16 | 72.84 | 305.77 | 502.55 | 58.90 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 111.99 | 75.74 | 314.48 | 499.74 | 60.20 |
20-Day Raw Stochastic | 46.46% | 30.15% | 10.63% | 35.66% | 35.10% |
20-Day Relative Strength | 58.46% | 49.00% | 51.20% | 52.96% | 53.35% |
Weighted Alpha | +67.32 | +6.21 | +10.59 | +19.33 | +23.41 |
Today's Opinion | 80% Buy | 24% Buy | 32% Buy | 64% Buy | 88% Buy |
Previous Opinion | 80% Buy | 8% Sell | 16% Buy | 88% Buy | 88% Buy |
Last Month's Opinion | 100% Buy | 24% Buy | 8% Buy | 40% Buy | 80% Buy |
Performance | |||||
5-Days | |||||
%Chg | +4.40% since 03/21/25 | -1.52% since 03/21/25 | -2.88% since 03/21/25 | -2.09% since 03/21/25 | -1.72% since 03/21/25 |
Low | 106.10 on 03/24/25 | 71.82 on 03/26/25 | 303.51 on 03/25/25 | 491.37 on 03/28/25 | 58.23 on 03/28/25 |
High | 112.38 on 03/28/25 | 75.12 on 03/25/25 | 317.58 on 03/24/25 | 513.97 on 03/24/25 | 61.49 on 03/25/25 |
1-Month | |||||
%Chg | -2.20% since 02/28/25 | -3.18% since 02/28/25 | -0.36% since 02/28/25 | +2.69% since 02/28/25 | +0.67% since 02/28/25 |
Low | 104.70 on 03/20/25 | 71.82 on 03/26/25 | 303.51 on 03/25/25 | 477.73 on 03/03/25 | 58.23 on 03/28/25 |
High | 119.96 on 03/10/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 519.68 on 03/14/25 | 63.33 on 03/11/25 |
3-Month | |||||
%Chg | +18.79% since 12/27/24 | +11.36% since 12/27/24 | +16.87% since 12/27/24 | +20.53% since 12/27/24 | +4.06% since 12/27/24 |
Low | 88.57 on 01/10/25 | 64.22 on 01/14/25 | 257.05 on 01/06/25 | 397.24 on 01/13/25 | 53.54 on 02/18/25 |
High | 119.96 on 03/10/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 519.68 on 03/14/25 | 63.33 on 03/11/25 |
6-Month | |||||
%Chg | +33.70% since 09/27/24 | -4.93% since 09/27/24 | -4.87% since 09/27/24 | +6.44% since 09/27/24 | +17.89% since 09/27/24 |
Low | 82.82 on 10/01/24 | 62.75 on 11/18/24 | 253.30 on 12/19/24 | 377.85 on 12/19/24 | 51.03 on 09/30/24 |
High | 119.96 on 03/10/25 | 79.76 on 10/02/24 | 335.88 on 03/10/25 | 519.88 on 11/08/24 | 63.33 on 03/11/25 |
Key Statistics | |||||
Market Capitalization, $K | 138,432,656 | 225,892,416 | 164,261,168 | 129,049,824 | 119,526,480 |
Shares Outstanding, K | 1,245,346 | 3,101,214 | 537,205 | 256,790 | 2,029,312 |
Annual Sales | 28,754,000,000 | 54,073,000,000 | 33,424,000,000 | 11,020,100,000 | 48,300,000,000 |
Annual Net Income | 480,000,000 | 7,035,000,000 | 4,090,000,000 | -535,600,000 | -8,948,000,000 |
Last Quarter Sales | 7,569,000,000 | 14,891,000,000 | 9,086,000,000 | 2,912,000,000 | 12,342,000,000 |
Last Quarter Net Income | 1,783,000,000 | 1,499,000,000 | 627,000,000 | 913,000,000 | 72,000,000 |
60-Month Beta | 0.21 | 0.41 | 0.53 | 0.41 | 0.43 |
Per-Share Information | |||||
Most Recent Earnings | 1.90 on 02/11/25 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 3.98 on 02/10/25 | 1.67 on 02/06/25 |
Latest Earnings Date | 04/24/25 | 04/24/25 | 05/01/25 | 05/05/25 | 04/24/25 |
Most Recent Dividend | 0.790 on 03/14/25 | 1.030 on 02/21/25 | 2.380 on 02/14/25 | N/A | 0.620 on 01/03/25 |
Next Ex-Dividends Date | 03/14/25 | 02/21/25 | 05/16/25 | N/A | 04/04/25 |
Ratios | |||||
Price/Earnings ttm | 23.70 | 17.69 | 15.42 | 0.00 | 51.94 |